KRAS mutation-induced EndMT of brain arteriovenous malformation is mediated through the TGF-β/BMP-SMAD4 pathway
Hongyuan Xu(Beijing Tian Tan Hospital), Yong Cao(Capital Medical University), Qiheng He(Capital Medical University), Ran Huo(Beijing Tian Tan Hospital), Jiancong Weng(China-Japan Friendship Hospital), Zihan Yan(Jinhua Academy of Agricultural Sciences), Yingfan Sun(Beijing Tian Tan Hospital), Shaozhi Zhao(Beijing Tian Tan Hospital), Hao Li(Capital Medical University), Jie Wang(Fudan University), Shuo Wang(Kailuan General Hospital), Yuming Jiao(Capital Medical University), Junze Zhang(Shenzhen University)
Cited by 30
Related Papers
The Third China National Stroke Registry (CNSR-III) for patients with acute ischaemic stroke or transient ischaemic attack: design, rationale and baseline patient characteristics
|Stroke and Vascular Neurology|2019|334
Mesenchymal stem cell therapy for ischemic stroke: A look into treatment mechanism and therapeutic potential
|Journal of Neurology|2020|132